Your browser doesn't support javascript.
loading
Molecular tools for the treatment of hepatitis C.
Pawlotsky, J M; Gretch, D R.
Afiliación
  • Pawlotsky JM; Department of Bacteriology and Virology, Hôpital Henri Mondor, Université Paris XII, Créteil, France.
Antivir Ther ; 3(Suppl 3): 45-55, 1998.
Article en En | MEDLINE | ID: mdl-10726055
The treatment of chronic hepatitis C is aimed at eliminating viral replication in order to prevent further evolution towards cirrhosis and hepatocellular carcinoma. Virological parameters include hepatitis C virus (HCV) genotype, qualitative viraemia, quantitative viral load and the characteristics of HCV quasi-species heterogeneity. These parameters can be used to predict and monitor the response to therapy, in order to help clinicians to tailor treatment of chronic hepatitis C and to better understand the molecular mechanisms underlying HCV resistance to antiviral drugs. Current knowledge on these various issues is reviewed in the present article.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Hepacivirus / Hepatitis C Crónica Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Antivir Ther Asunto de la revista: TERAPIA POR MEDICAMENTOS / VIROLOGIA Año: 1998 Tipo del documento: Article País de afiliación: Francia
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Hepacivirus / Hepatitis C Crónica Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Antivir Ther Asunto de la revista: TERAPIA POR MEDICAMENTOS / VIROLOGIA Año: 1998 Tipo del documento: Article País de afiliación: Francia